Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the complete response rate when CHOP-R chemotherapy
in followed by Zevalin in previous untreated patients with follicular lymphoma